Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Bobthebuilddron Jan 13, 2017 1:40pm

102 Views

Post# 25705241

RE:RE:RE:Anyone know why KALI is halted?

1 billion dollar company for sure. How many shares should I buy 200k? Lolz.

sunny3999 wrote: Looks like there is something big on the way, hopefully Aphria is named in the game:

Link: Look at the names where Kalytera Therapeutics is named with: GW Pharma, Bayer, Novartis....all have billions on Marketcap

:
Excerpt
Another small fry is Kalytera Therapeutics (TSXV: KALY), which is developing a new class of proprietary cannabidiol (CBD) therapeutics. CBD is a pot-based compound that has shown promise treating diseases but there are limitations associated with natural CBD, including its short half-life and poor efficacy when administered orally.

Low “oral bioavailability” in clinical trials is a major reason for drug candidates failing to reach the market. Kalytera is testing new CBD formulations to overcome these limitations.

premium54 wrote: Yes becuase there is news pending.